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Abstract
Objective—To investigate the association of single nucleotide polymorphisms (SNPs) within 
genes involved in inflammation, skin barrier integrity, signaling/pattern recognition and 
antioxidant defense with irritant susceptibility in a group of health care workers.
Materials and Methods—The 536 volunteer subjects were genotyped for selected SNPs and 
patch tested with three model irritants: sodium lauryl sulfate (SLS), sodium hydroxide (NaOH) 
and benzalkonium chloride (BKC). Genotyping was performed on genomic DNA using Illumina 
Goldengate custom panels.
Results—The ACACB (rs2268387, rs16934132, rs2284685), NTRK2 (rs10868231), NTRK3 
(rs1347424), IL22 (rs1179251), PLAU (rs2227564), EGFR (rs6593202) and FGF2 (rs308439) 
SNPs showed association with skin response to tested irritants in different genetic models (all at 
p<0.001). Functional annotations identified two SNPs in PLAU (rs2227564) and ACACB 
(rs2284685) genes with a potential impact on gene regulation. In addition, EGF (rs10029654), 
EGFR (rs12718939), CXCL12 (rs197452), and VCAM1 (rs3917018) genes showed association 
with hand dermatitis (p<0.005)
Conclusions—The results demonstrate that genetic variations in genes related to inflammation 
and skin homeostasis can influence responses to irritants and may explain inter-individual 
variation in the development of subsequent contact dermatitis.
*Address correspondence to: Berran Yucesoy, PhD, Formerly of the Health Effects Laboratory Division, National Institute for 
Occupational Safety and Health, Morgantown WV, berranyucesoy@gmail.com. 
Conflicts of interest: The authors declare no conflict of interest.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the 
National Institute for Occupational Safety and Health.
HHS Public Access
Author manuscript
J Occup Environ Med. Author manuscript; available in PMC 2017 August 01.
Published in final edited form as:














irritant contact dermatitis; genetics; health care workers
INTRODUCTION
Irritant contact dermatitis (ICD) is an inflammatory response of the skin to a variety of 
triggers in the absence of sensitization and accounts for 50–80% of all occupational 
dermatitis cases. 1,2,3 ICD is commonly seen in people who have repetitive contact with 
weak irritants (i.e. rapid evaporation of water especially in the presence of detergents and 
soaps) and mainly effects hands. 4 At risk industries include (but are not limited to) those 
that involve “wet work” such as healthcare, printing, metal machining, food preparation, 
painting, and beauty services. A number of internal (e.g., atopy, age, sex, body region and 
genetic predisposition) and external (e.g., physical and chemical properties of the irritant, 
concentration, exposure duration) factors influence susceptibility to ICD. External factors 
trigger a number of events including skin barrier disruption, activation of epidermal 
keratinocytes, cellular damage, and release of inflammatory mediators such as cytokines, 
chemokines and adhesion molecules. 5
There is wide biological variation in skin response to irritants, and susceptibility factors 
involved in the regulation of epidermal homeostasis are still largely unexplored. Given the 
role of cytokines in inflammatory processes, genetic polymorphisms in several cytokine 
genes, including tumor necrosis alpha (TNFα), interleukin-1 alpha (IL-1α), IL-1β, IL-8, 
IL-10, have been investigated. Among those, TNFα -308 and IL1A-889 SNPs were found to 
be associated with susceptibility to ICD. 6-10 Polymorphisms in the filaggrin (FLG) gene 
(R501X and 2282del4) have also been shown to be predisposing factors for atopic dermatitis 
and chronic ICD. 11-13 However, conflicting results have been reported and no clear 
association was established between clinically diagnosed or experimentally-induced irritant 
dermatitis and FLG variations. 14-18
In the present study, we aimed to comprehensively investigate the association of genetic 
variations in selected candidate genes involved in inflammation, skin barrier integrity, 
signaling/pattern recognition, and antioxidant defense with irritant susceptibility. Since acute 
inflammatory response in epidermis depends on the chemical structure of the applied 
irritant. 19 three structurally different irritants, sodium lauryl sulfate (SLS), NaOH (sodium 
hydroxide) and benzalkonium chloride (BKC), were used as model irritants. To date, most 
published studies have investigated a small number of genes and/or SNPs and focused on 
clinical ICD. In this regard, assessing variability in skin response to experimental irritants 
under controlled conditions may provide insights into the mechanism underlying ICD risk.
METHODS
Study population
The study population consisted of 536 health care workers (nurses, physicians, and 
technicians) from the two participating University Hospitals (Case Medical Center and West 
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Virginia University Hospitals). Volunteers with no history of psoriasis and or inflammatory 
skin disease requiring medical attention and capable of giving informed consent were 
recruited for the study. A history of or current mild irritant hand dermatitis or intermittent 
chapped hands were not an exclusion criterion. Subjects who were pregnant, using 
immunosuppressive, immunomodulatory or anti-inflammatory medications, or receiving 
ultraviolet therapy or tanning salon usage were excluded. The volunteers’ current skin 
condition was classified at each study visit by a dermatologist based on objective skin 
symptoms as mild, moderate, or severe hand dermatitis. Moderate or severe dermatitis is 
characterized by erythema, papules, vesicles, fissures, exhibiting a clear eczematous picture. 
Mild dermatitis is exhibited as erythema, slight chapping, and scaling of the skin. 
Information on participants’ health status (e.g., asthma, dermatitis/eczema, seasonal 
allergies, family history of dermatitis) and skin exposure history (e.g., the number of daily 
hand washings and use of soap or hand cleanser) were collected by questionnaire. Blood 
samples were collected for genetic analysis. Study procedures were approved by the 
Institutional Review Boards of participating institutions. The demographics variables of the 
participants that were included in the analysis are given in Table 1.
Genotyping and SNP selection
Genotyping—Whole blood samples were collected for genetic analysis and genomic DNA 
was extracted using the QIAamp blood kit (QIAGEN Inc., Chatsworth, CA). Genotyping 
was performed according to the Illumina Golden Gate protocol (Illumina Inc., San Diego, 
CA). A total of 250 ng to 1μg DNA was used for each assay depending on the source. 
Genotypes were auto called using GenomeStudio software (Illumina, Inc., San Diego, CA). 
An oligonucleotide pool assay (OPA) was designed by selecting candidate genes that are 
known and/or suspected to be involved in the ICD process. In SNP selection, 10 kb upstream 
and 10 kb downstream regions were included in accordance with design score validations 
and SNPs closer than 60 bp to another SNP were excluded to accommodate the assay. The 
SNPs included in the OPA had a MAF of >5% in HapMap/CEU population. Selected genes 
and their chromosomal locations are presented in Supplementary Table 1.
Model irritants, patch testing, and transepidermal water loss (TEWL)—Sodium 
lauryl sulfate (SLS) (99% pure), sodium hydroxide (NaOH) and benzalkonium chloride 
(BKC) (Sigma-Aldrich Co. LLC., San Louis, MO) were employed as model irritants. 
Aqueous solutions of SLS at concentrations of 0.1%, 0.25%, 0.5%, 1.0%, 2.5%, 5.0%, 10% 
and 20%, NaOH at concentrations of 0.1%, 0.25%, 0.5%, 1.0%, 2.5% and 5.0% and BKC at 
concentrations of 0.1, 0.5, 1.0, 2.5 % were applied in 0.2 ml volumes to 5 mm Finn 
Chambers (Allerderm, Petaluma, CA) and affixed to the intact, non-inflamed skin of the 
back with Scanpor tape. Since patch tests for irritant contact dermatitis are not standardized, 
a range of concentrations was used in the first phase of our study to determine the 
concentrations which resulted in inter-individual variation of response. Distilled water 
served as a negative control. 20% SLS, the minimum level classified as irritant (R38) by 
European Commission criteria, served as a positive control. Subjects wore the taped patches 
for 24 hours and reactions were graded by visual assessment of the patch sites using a 3 
point grading scale of increasing irritation (‘0’ no reaction; ‘+’ weakly positive reaction 
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characterized by mild erythema across most of the treatment site; ‘++’ strong positive 
reaction characterized by spreading erythema with edema). 20
The transepidermal water loss (TEWL), an indicator of the skin barrier integrity, was 
measured using an evaporimeter (VapoMeter SWL4, Delfin Technologies, Kuopio, Finland). 
Three readings (g/m2h) at each site were taken from the upper inner arm, from the back, and 
from the side of forefinger and the means were calculated. The inner arm and back sites 
were assessed as these would be expected to show high TEWL in patients with genetic 
barrier defect e.g. atopic dermatitis, whereas the forefinger would be expected to have higher 
TEWL both from genetic barrier defects and from environmental factors such as wet-dry 
cycles due to hand washing. These wet-dry cycles are more pronounced in low humidity 
conditions when indoor heating is used in cold weather.
Study design—The study was conducted in a cross-sectional study design in two phases. 
Phase I was designed to determine an effective concentration range for each irritant (using 
concentration ranges given above) that would be used for the second phase. Forty health care 
workers were assessed in this phase. Individual differences in skin response were observed 
starting at concentrations of 2.5% SLS, 1% NaOH and 0.5% BKC. Based on this, the 
concentration range for Phase II was set as: 2.5%, 5.0% and 20% of SLS; 1%, 2.5% and 
5.0% of NaOH; and 0.5%, 1.0% and 2.5% of BKC.
Statistical analyses—SNP-specific deviations from the Hardy-Weinberg Equilibrium 
were tested using chi-squared goodness-of-fit tests. Responsiveness to three concentrations 
of each irritant was coded as low for no response, medium (moderate) for a weakly positive 
macular reaction, and high for a papular or vesicular reaction. These variables were turned 
into binary variables by calling low responders as controls and moderate and high 
responders as cases and included in the logistic regression analysis. The genotype 
confidence score of the assay was set to 0.25 in GenomeStudio Genotyping module. Alleles 
that were not called in a sample were coded as missing in the analysis. A threshold of 2% 
was used for missing rates per individual and per SNP. For each dataset SNPs were called 
and filtered separately and then merged using PLINK version 1.07. 21 The final dataset 
contained 1074 SNPs for 536 subjects. The total genotype rate for the dataset was 0.99.
Statistical analysis was performed using PLINK. Since underlying genetic models are 
unknown a priori, several different models were tested and overall significance of test results 
confirmed by exploring functional elements in linkage disequilibrium with our interesting 
findings. As such, we used a conservative discovery-based threshold for p-values 
corresponding to a=0.001, without any multiple testing correction, as this study is meant to 
be exploratory and hypothesis generating. Association between each SNP and irritant 
response was analyzed using three genetic models, that included a dominant model 
(comparing homozygous wild-type vs. variant allele-carrying genotypes), recessive model 
(comparing wild-type allele-carrying vs. homozygous variant genotypes), and an additive 
model (cumulative effect of each additional variant allele). Logistic regression model, with 
adjustments for potential cofounders was used to test for differences between irritancy 
thresholds according to genotypes. Potential confounders were separately selected for each 
irritant from a larger set of measured variables using group comparison of the means 
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between cases and controls. Any variable that had a significant difference in the means was 
then used in stepwise regression model to eliminate any confounder that did not have any 
influence on the outcome variable. Based on this, skin responses to SLS were adjusted for 
gender, population (represents different recruitment sites), season (coded binary as cold vs 
warm) and indoor humidity when the patch test was interpreted. Skin responses to NaOH 
were adjusted for gender, population and indoor humidity, while responses to BKC were 
adjusted only for gender and population. Based on a stepwise regression model, age did not 
appear to significantly affect skin responses. However, we repeated analysis with additional 
adjustment for age and compared the results with those obtained by the final model.
In order to test the association of SNPs with the development of ICD, subjects were assigned 
to the case or control group based on the development of hand dermatitis during the study 
period. Since ICD from wet work, as in our cohort of health care workers usually occurs 
during cold months (October-March), only subjects examined during these months were 
included in this analysis. 22 This prevented erroneously including subjects who might 
develop wintertime ICD in the control group. The measured variables were individually 
tested for association with hand dermatitis and stepwise regression model was used to 
eliminate any confounder that did not have any influence on the outcome. Based on this, the 
results were adjusted for hand washing frequency and TEWL measurement on the 
forefinger. The results were not corrected for multiple comparisons since our analysis was 
based on the defined biological role of selected genes. Instead, we reported all tests that 
reached a (p<0.001 for skin irritant response and p<0.005 for ICD) level of significance and 
highlighted the functional relevance of significantly associated SNPs.
Linkage disequilibrium (LD) and haplotype blocks were assessed using default parameters 
in Haploview. 23 Pairwise LD was calculated only for SNPs within 200kb. RegulomeDB was 
used to annotate SNPs with known and predicted regulatory elements. 24 SNAP tools were 
used to update annotations of interesting SNPs according to dbSNP135 and to find proxy 
SNPs within 500kb based on LD and physical distance. 25
RESULTS
Characteristics of the study subjects
The demographics variables of the participants that were included in the analysis are 
described in Table 1. The main study population consisted of 654 health care workers. 118 
subjects were excluded from the analyses due to ineligibility or incomplete information, 
leaving 536 subjects for the final analysis. The mean age of the population was 36 with the 
majority (451) being female. While 15.3% of the study population had a family history of 
dermatitis or eczema, 22.4% had hand dermatitis at any time during the study.
Association between SNPs, irritancy threshold and ICD
A number of samples were excluded from the analyses due to incomplete genotype 
information. The custom panel allowed examination of 1074 SNPs in 188 genes. All 
genotype frequencies were in Hardy Weinberg Equilibrium. After adjusting for confounders, 
a number of SNPs in genes that code for ACACB (Acetyl-CoA Carboxylase Beta), NTRK2 
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(Neurotrophic Tyrosine Kinase, Receptor, Type 2), NTRK3 (Neurotrophic Tyrosine Kinase, 
Receptor, Type 3), IL22 (interleukin 22), PLAU (Plasminogen Activator, Urokinase), EGFR 
(Epidermal Growth Factor Receptor ), and FGF2 (Fibroblast Growth Factor 2) were 
significantly associated with skin irritation response. We reported any SNP that reached a 
discovery threshold level p<0.001. Table 2 summarizes the associations found in three 
genetic models that reached a significant level (p<0.001). Additional adjustment for age did 
not change the p values. The ACACB (rs2268387 and rs16934132) SNPs were associated 
with response to 2.5% SLS, whereas NTRK2 (rs10868231) SNP was associated with 
response to 5% SLS. Another ACACB (rs2284485) SNP was associated with the response to 
the highest dose (20%) of SLS. The IL22 (rs1179251) SNP was associated with response to 
1% NaOH, while the PLAU (rs2227564) and EGFR (rs6593202) SNPs were also associated 
with response to 2.5% and 5% of NaOH respectively. Finally the FGF2 (rs308439) and 
NTRK3 (rs1347424) SNPs showed association with response to 0.5% and 1% BKC 
respectively. None of the other polymorphisms that were examined showed any significant 
association with the irritancy response.
A regression analysis showed that SNPs in EGF (rs10029654), EGFR (rs12718939), 
CXCL12 (rs197452), and VCAM1 (rs3917018) genes were significantly associated with 
hand dermatitis (p<0.005) after adjusting for potential confounders (Table 3). P values that 
reached the same significance level after additional adjustment for age are marked in bold.
Association between haplotypes and skin irritant response
Variation in response to irritants was significantly associated with three haplotypes (TA, 
AGA, GGG). Table 4 shows these haplotypes and their frequencies. TA haplotype 
constructed by SNPs that were mapped to the NTRK2 gene was associated with response to 
2.5% NaOH. Both AGA and GGG haplotypes were correlated with response to 5% NaOH 
and constructed by SNPs that were mapped to the EGFR gene. These haplotypes contained 
the rs6593202 SNP that was also identified in the logistic regression analysis.
Regulatory information for significant associations
The significant SNPs identified from initial analyses were used as input to the SNP 
Annotation and Proxy Search (SNAP) tool 25 to find additional SNPs in complete linkage 
disequilibrium (using an r2 of 1). A combination of the original and correlated SNPs were 
then used as input to the RegulomeDB 24 web resource, which integrates data from the 
ENCODE projects and other data sources regarding various types of functional assays 
including DNaseI-seq, ChIP-seq, RNAseq, and eQTL analyses. SNPs with RegulomeDB 
scores between 1 and 3 (inclusive, where scoring refers to available data types supporting a 
functional role for the variant) are listed in Table 5. PLAU (rs2227564) and ACACB 
(rs2284685) SNPs were found to regulate the expression of ECD and KCTD10 genes, 
respectively.
Regarding association with hand dermatitis, functional annotations showed that VCAM1/
rs3917018 SNP (RegulomeDB score = 3a) affects binding of POLR2A (Polymerase (RNA) 
II (DNA Directed) Polypeptide A) and falls within CUX2 (Cut-Like Homeobox 2), FOXO1 
(Forkhead Box O), FOXO4, and FOXO6 binding motifs. While rs12718939 and rs197452 
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SNPs showed minimal binding evidence (RegulomeDB scores 5 and 6), the rs10029654 
returned with “no data” score.
DISCUSSION
We previously reported an association between individual irritation responsiveness and the 
risk for hand dermatitis in our study population. Subjects with a positive patch test to 2.5% 
SLS were more likely to have occurrence of hand dermatitis (IRR=1.78, 95% CI: 0.92, 
3.45). 22 In the present study, we investigated the genetic basis of irritant susceptibility in a 
larger healthcare workers population and identified nine significant SNPs in seven candidate 
genes. The ACACB SNPs (rs2268387, rs16934132 and rs2284685) showed association with 
response to low and high levels of SLS in different genetic models. The enzyme encoded by 
the ACACB gene is involved in the synthesis of fatty acids. Its role in protecting skin barrier 
was shown in a murine model where increased mRNA expression was observed after barrier 
disruption. 26 Buraczewska et al. reported an association between high expression of 
ACACB and low transepidermal water loss (TEWL) in untreated skin. 27 Another study 
investigating skin barrier restoration after exposure to SLS showed ACACB to be one of the 
important genes in lipid synthesis and skin barrier repair. 28 Although the regulation of 
ACACB in keratinocytes is not completely understood, altered expression of lipid 
processing regulators, such as peroxisome proliferator-activated receptors (PPARa and 
PPARc), in SLS-exposed skin and the correlation between TEWL and ACACB argues for 
the relevance of the gene in skin barrier formation and homeostasis. 29,30 It is possible that 
altered levels of ACACB lead to increased penetration of irritants through the skin, and 
subsequent development of inflammation. Based on this, it is biologically plausible that 
genetic variations in the ACACB gene may influence its regulation and consequently result 
in inter individual variation in response to irritant exposure.
The IL-22 rs1179251 SNP was associated with skin response to 1% NaOH. Recent studies 
showed the importance of IL-22 in skin barrier impairment. IL-22 was found to increase 
epidermal barrier dysfunction by down-regulating filaggrin and the enzymes involved in 
profilaggrin to filaggrin processing. 31 IL-22 has also been reported to promote epidermal 
hyperplasia, inhibit the differentiation of keratinocytes and promote their migration and 
plays a role in regulating antimicrobial peptides (AMPs) and matrix metalloproteinase 
(MMP) in epidermis. 32-37 High levels of IL-22 expression have been observed in chronic 
atopic dermatitis and its levels were positively associated with severity of disease. 38 
Interestingly, atopic dermatitis is known to be worsened by alkaline pH, and NaOH is a very 
alkaline irritant. IL-22 was also shown to mediate IL-23-induced epidermal 
hyperproliferation and dermal inflammation in psoriasis. 39,40 Although not studied in the 
context of skin irritancy, genetic variations of the IL22 gene have been associated with 
psoriasis and its severity. 41-43 Our results show, for the first time, that genetic variability 
within IL-22 may also contribute to skin irritant response.
The PLAU rs2227564 and EGFR rs6593202 SNPs were associated with skin responses to 
medium and high levels of NaOH, respectively. The Plau [urokinase-type plasminogen 
activator (U-PA)] has been shown to be expressed in skin keratinocytes and known to be 
involved in degradation of the extracellular matrix.44 Although there is no information 
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related to role of PLAU in skin irritation responses, a recent study reported that extended 
increased expression of extracellular matrix-related genes (e.g., Col3A1, TGFβ3) including 
PLAU was associated with hypertrophic scar formation.45
EGFR signaling plays a role in keratinocyte proliferation and differentiation and ultimately 
influences the wound healing process. 46-48 The EGFR signaling pathway was found to be 
crucial for skin development and homeostasis. 49 Increased EGFR expression was found in 
chronic inflammatory skin diseases including psoriasis and atopic dermatitis, possibly by 
regulating cytokine and chemokine secretion by keratinocytes. 49-51 Polymorphisms in the 
EGFR gene have been investigated in relation to skin rash observed after cancer treatment 
with EGFR-inhibitors, and there are studies assessing their contribution to the innate 
immune response which mediates the skin responses induced by irritants. 52 This finding 
extends our knowledge of the role of EGFR gene variations in skin homeostasis.
The FGF2 rs308439 SNP was associated with response to medium and high levels of BKC. 
FGF2 is known to be a potent angiogenic factor and endothelial cell mitogen and has been 
implicated in diverse biological processes including wound healing. It was shown that FGF2 
enhances the recruitment of monocytes, T cells, and PMNs in response to various 
inflammatory stimuli and increases expression of adhesion molecules on cytokine-activated 
epithelial cells. 53 The presence of angiogenic factors including FGF2 has been associated 
with more intense accumulation of leukocytes and exacerbation of injury during 
inflammation. 54,55 SNPs in NTRK2 (rs10868231) and NTRK3 (rs1347424) genes were 
associated with responses to medium levels of SLS and BKC. However, the roles of NTRK2 
and NTRK3 genes have not been characterized in the skin. Although there is no information 
about the role of significant genes and their variations in irritancy response, their biological 
role in skin homeostasis and previous reports on their role in inflammatory processes 
support our findings.
Haplotype analysis showed that SNPs within the haplotype blocks mapped to NTRK2 and 
EGFR genes. Two haplotypes (AGA and GGG) included a SNP (rs6593202) that was 
identified by logistic regression analysis (Table 2). These findings further support the 
involvement of EGFR and NTRK2 in skin irritant responses. Functional annotations showed 
that PLAU rs2227564 and ACACB rs2284685 SNPs regulate ECD (Ecdysoneless) and 
KCTD10 (potassium channel tetramerisation domain containing 10) genes, respectively. 
Although KCTD10 may be associated with DNA synthesis and cell cycle control 56,57 the 
biological role of these genes has not been fully characterized and there was no information 
pertaining to the possible role of these genes in skin irritation response. As such, the results 
should be considered preliminary but should allow for more direct studies into the 
associations that were identified.
Examination of our subjects for development of ICD on the hands revealed that SNPs in 
EGF (rs10029654), EGFR (rs12718939), CXCL12 (rs197452), and VCAM1 (rs3917018) 
genes were associated with ICD after adjusting for potential confounders. Among these 
SNPs, only the VCAM1/ rs3917018 showed functional evidence. VCAM1 is an adhesion 
molecule that plays a role in skin inflammatory responses. 58 RegulomeDB showed that the 
rs3917018 affects the binding of POLR2A and overlaps with CUX2 and FOXO (1,4, and 6) 
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binding motifs. They all play a role in the regulation of transcription. FOXO transcription 
family is also known to be involved in wound healing. 59 The association of this SNP with 
ICD could be related to its overlap with these binding motifs. EGF, EGFR, and CXCL12 are 
known to play important roles in epithelial homeostasis and wound healing. 47,60,61 EGFR 
has been shown to be essential for toll-like receptor signaling which is a key player in innate 
immunity. 52,62,63 EGF family members have also been shown to be involved in cutaneous 
immune/inflammatory responses. 64 In the present study, EGFR variants showed association 
with both skin irritant response and ICD. Since ICD is mediated by the innate immune 
system, it is plausible to expect that EGFR variants may play a role in the ICD process. 
However, since no functional data is available for SNPs in these genes, it is difficult to 
determine their exact involvement in ICD pathogenesis.
Limitations of our study include the exclusion of subjects with a history of inflammatory 
skin disease requiring medical attention which likely decreased the prevalence of atopic 
dermatitis patients in our cohort. Also, chronic exposure to irritants may result in 
‘hardening’ which may have reduced acuity of dermatitis and caused failure to detect some 
cases on examination. In addition, the healthy worker effect may have caused some 
genetically predisposed patients to change careers and reduced their representation in our 
cohort. Also, we were unable to study filaggrin (FLG) mutations that were found to be 
associated with atopic dermatitis in this analysis. Only two FLG SNPs, rs11582620 and 
rs2184953, were included in the final panel due to low designability rank scores of most 
commonly studied FLG SNPs [i.e. rs61816761 (R501X), rs41370446 (2282del4)]. This 
prevents comparison to prior literature reporting associations between atopic dermatitis and 
FLG variants rs61816761, rs41370446, rs138726443 (R2447X), and rs150597413 
(S3247X). 11,12,17 The SNPs included in our study have not been studied in Caucasians. 
However, our results are in line with two other studies reporting no association between 
these SNPs and atopic dermatitis in Japanese population. 65,66
The p-value results in this study were not corrected for multiple comparisons since our 
analysis was based on the well-defined role of the selected genes in skin irritation response 
and we were interested in generating hypotheses for further study rather than being the 
definitive study of genetic associations of these genes. We reported all test results that 
reached a discovery threshold of p<0.001 and highlighted the functional relevance of 
associated SNPs to determine which might be interesting results to follow up on.
To our knowledge, this is the first report implicating ACACB, NTRK2, NTRK3, IL-22, 
PLAU, EGFR, FGF2 gene variants in irritant susceptibility in a high risk occupational 
population. Although the exact mechanism underlying enhanced susceptibility remains to be 
determined, these SNPs seem to modify skin response to irritants and contribute 
significantly to chemical irritancy threshold. Large prospective studies are warranted to 
confirm these findings and identify causative alleles using high-density genome scans. 
Genetic markers for predisposition to specific irritants may be useful to choose 
individualized hand hygiene methods. Genetic mechanisms underlying ICD may also be 
helpful to guide development of new therapies. Because ICD creates ‘danger signals’ that 
predispose to allergic contact dermatitis, prevention of ICD would be expected to reduce the 
development of the more debilitating occupational allergic contact hand dermatitis as well.
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Table 1
Demographics of the study population
Demographics N=536
Age (median, range) 36, 18-70
Gender (F/M/missing) 451/67/18
Ethnicity (non-hispanic whites/others/missing) 483/29/24
Season (warm vs. cold) * 331/205
Population (WVU vs. CWU) ** 459/77
Family history of dermatitis or eczema (%) 15.3
Hand Dermatitis (%) during any research visit 22.4
TEWL
 Arm (median, range) 9.7, −5.8 − 65.53
 Back (median, range) 9.5, 7.67 − 173.5
 Forefinger (median, range) 21.3, −6.53 − 96.8
*
Season variable was coded according to time of patch testing: warm - April through September; cold - October through March
**
Population variable represents the location of subject recruitment (WVU-West Virginia University; CWU-Case Western Reserve University)
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Table 5
Regulatory potential of associated/correlated SNPs and affected genes
Chr SNP BP eQTL Reference
chr10 rs2227564 75673100 ECD [67]
chr12 rs2284685 109686781 KCTD10 [68]
BP: Physical position of the SNP
eQTL: List of genes affected by significant SNPs
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